Robbins Farley’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.7K Hold
150
0.02% 87
2025
Q4
$31K Hold
150
0.01% 93
2025
Q3
$27.8K Hold
150
0.01% 99
2025
Q2
$22.9K Hold
150
0.01% 98
2025
Q1
$24.9K Hold
150
0.01% 91
2024
Q4
$21.7K Sell
150
-10
-6% -$1.55K 0.01% 94
2024
Q3
$25.9K Buy
160
+10
+7% +$1.59K 0.01% 90
2024
Q2
$21.9K Hold
150
0.01% 92
2024
Q1
$23.7K Hold
150
0.01% 91
2023
Q4
$23.5K Sell
150
-50
-25% -$7.67K 0.01% 91
2023
Q3
$31.1K Hold
200
0.02% 89
2023
Q2
$33.1K Sell
200
-46
-19% -$7.42K 0.02% 81
2023
Q1
$38.1K Hold
246
0.03% 79
2022
Q4
$43.5K Buy
246
+46
+23% +$7.94K 0.03% 72
2022
Q3
$33K Hold
200
0.03% 73
2022
Q2
$36K Hold
200
0.04% 54
2022
Q1
$35K Hold
200
0.03% 65
2021
Q4
$34K Hold
200
0.03% 62
2021
Q3
$32K Hold
200
0.02% 70
2021
Q2
$33K Buy
+200
New +$33.1K 0.04% 42
2021
Q1
Sell
-150
Closed -$24K 185
2020
Q4
$24K Buy
+150
New +$22.1K 0.02% 55

Other funds holding JNJ

Robbins Farley's JNJ Position: Q1 2026 in Review

Robbins Farley held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 150 shares worth $36.7K. The position accounts for 0.02% of the portfolio, ranked #87.

Robbins Farley first reported a position in JNJ in Q4 2020 and has held it in 21 quarters since. The position peaked at $43.5K in Q4 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Robbins Farley held 150 shares of Johnson & Johnson worth $36.7K as of Q1 2026.
  • Robbins Farley left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.02% of Robbins Farley's portfolio in Q1 2026, its #87 holding.
  • Robbins Farley first reported a position in Johnson & Johnson in Q4 2020 and has held it in 21 quarters since.
  • Robbins Farley's Johnson & Johnson position peaked at $43.5K in Q4 2022.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Robbins Farley's 13F filing for Q1 2026, filed 17 Apr 2026.